InvestorAndreessen Horowitz, also known as a16z, is a prominent venture capital firm based in Silicon Valley, founded in 2009. The firm invests across various sectors, supporting companies from early-stage startups to growth-stage firms.
Global BioAccess Fund
Global BioAccess Fund is an investment firm based in New York, focusing on early-stage biopharmaceutical companies. It invests in transformative technologies addressing unmet medical needs in various therapeutic areas.
Online destinations
Find Global BioAccess Fund online
Where to find this organization online, grouped by who runs each page. A link here does not mean the organization controls it.
Official links
Pages the organization runs itself.
Overview
The Global BioAccess Fund is an investment banking firm founded to partner with companies in the biopharmaceutical sector. Based in New York, it focuses on investing in transformative technologies aimed at addressing unmet medical needs. The fund invests in early-stage companies developing novel therapeutics and devices in fields such as Oncology, Immunology, cardiovascular diseases, CNS disorders, and rare diseases. Typically, the fund invests from Series A to Series C rounds, with the capacity to invest up to $10 million throughout a company's lifespan, primarily in the United States but also open to international partnerships.
Focus
The Global BioAccess Fund primarily invests in early-stage companies from Series A to Series C rounds, with a focus on transformative technologies in the biopharmaceutical sector. The fund typically invests up to $10 million throughout a company's lifespan, emphasizing partnerships with companies that are addressing critical medical needs, particularly in the United States, but also considering opportunities globally.
Support
The Global BioAccess Fund adds value to its portfolio companies by providing not only capital but also strategic guidance and industry expertise. The team, comprised of experienced professionals in the biopharmaceutical sector, works closely with founders to navigate challenges, refine business strategies, and accelerate growth, ultimately aiming to enhance the impact of their innovations in healthcare.
Questions
What are the investment criteria for the Global BioAccess Fund?
The fund primarily invests in early-stage companies from Series A to Series C rounds, focusing on transformative technologies in the biopharmaceutical sector. Key sectors include Oncology, Immunology, Inflammation, cardiovascular diseases, CNS disorders, and rare diseases.
How can startups apply or pitch to the Global BioAccess Fund?
Startups can reach out via email at info@globalbioaccess.com to initiate discussions about potential investment opportunities. A detailed pitch deck outlining the business model, market potential, and team background is recommended.
What makes the Global BioAccess Fund different from other investors?
The firm combines capital investment with strategic guidance and industry expertise, providing portfolio companies with valuable insights to navigate challenges and accelerate growth.
What is the geographic scope of the Global BioAccess Fund?
While the primary focus is on the United States, the fund is open to partnering with companies from other countries that align with its investment thesis.
What is the typical check size for investments?
The Global BioAccess Fund typically invests between $1 million and $10 million throughout a company's lifespan, depending on the specific needs and growth potential of the business.
What kind of post-investment involvement does the fund have?
The fund actively engages with its portfolio companies, providing strategic guidance and support to help refine business strategies and enhance growth potential.
Check your startup’s fit
Check your startup’s fit with Global BioAccess FundSimilar investors
Organizations that do similar work to Global BioAccess Fund.
Investor
InvestorSequoia Capital is a venture capital firm based in Silicon Valley, established in 1972. It invests in technology companies at various stages, focusing on long-term partnerships with founders.
InvestorKleiner Perkins is a venture capital firm based in Menlo Park, California, founded in the 1970s. It partners with entrepreneurs across various sectors, providing capital and resources from inception to IPO.
InvestorInvest in the future with OurCrowd.
Superscout Pro
Find faster. Show up verified. Keep your deals private.
$99a year, or $12 a month
Get Pro- Search that narrowsInvestors, programs, accelerators, incubators and studios, by stage, sector and place.
- A verified profileThe people you reach know you are who you say you are.
- A private deal vaultThe startups you are watching, with your notes and your reasons. Nobody else's eyes.
Is this page right?Reviewed · How the research works